» Articles » PMID: 29762458

Association Between Duration of Delayed Graft Function, Acute Rejection, and Allograft Outcome After Deceased Donor Kidney Transplantation

Overview
Journal Transplantation
Specialty General Surgery
Date 2018 May 16
PMID 29762458
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Prolonged duration of delayed graft function (DGF) may be associated with adverse allograft outcomes, but the association between threshold duration of DGF, acute rejection and long-term allograft loss remains undefined. We aimed to determine the impact of DGF duration on allograft outcomes and to assess whether this association was mediated by acute rejection.

Methods: Using data from the Australian and New Zealand Dialysis and Transplant Registry, Cox proportional modeling was used to determine the association between quartiles of DGF duration, acute rejection at 6 months and death-censored graft loss (DCGL). Mediation analysis was conducted to determine whether acute rejection was a causal intermediate between DGF and DCGL.

Results: Of 7668 deceased donor kidney transplants between 1997 and 2014, 1497 (19.5%) recipients experienced DGF requiring dialysis. The median (interquartile range) duration of DGF was 7 (9) days, with 25% requiring dialysis for 14 days or longer. Among recipients who had experienced a DGF duration of 1 to 4 days, the adjusted hazard ratio for duration of 5 to 7, 8 to 13, and 14 days or longer were 1.13 (95% confidence interval [CI], 0.83-1.55; P = 0.43), 1.44 (95% CI, 1.08-1.91; P = 0.013), and 1.99 (95% CI, 1.50-2.65; P < 0.001), respectively, for acute rejection; and were 1.10 (95% CI< 0.73-1.67; P = 0.64), 1.45 (95% CI, 1.00-2.11; P = 0.05) and 1.60 (95% CI, 1.10-2.31; P = 0.01), respectively, for DCGL. On average, 8% of the effects between DGF duration and DCGL were explained by acute rejection.

Conclusions: There was a direct dose-dependent effect between DGF duration and DCGL, with acute rejection explaining less than 10% of the effects between DGF duration and DCGL. Future research identifying other potential modifiable mediators that lies in the causal pathway between DGF duration and allograft loss is essential.

Citing Articles

Can Novel Biomarkers Effectively Predict Acute Kidney Injury in Liver or Kidney Transplant Recipients?.

Zywno H, Figiel W, Grat M, Nazarewski S, Galazka Z, Malyszko J Int J Mol Sci. 2024; 25(22).

PMID: 39596140 PMC: 11593440. DOI: 10.3390/ijms252212072.


Deceased Kidney Donor Biomarkers: Relationship between Delayed Kidney Function and Graft Function Three Years after Transplantation.

Maslauskiene R, Vaiciuniene R, Tretjakovs P, Gersone G, Radzeviciene A, Bura A Diagnostics (Basel). 2024; 14(7).

PMID: 38611630 PMC: 11011901. DOI: 10.3390/diagnostics14070717.


Characteristics of Delayed Graft Function and Long-Term Outcomes After Kidney Transplantation From Brain-Dead Donors: A Single-Center and Multicenter Registry-Based Retrospective Study.

Ahlmark A, Sallinen V, Eerola V, Lempinen M, Helantera I Transpl Int. 2024; 37:12309.

PMID: 38495816 PMC: 10942003. DOI: 10.3389/ti.2024.12309.


Delayed Graft Function and the Renin-angiotensin System.

Yamani F, Cianfarini C, Batlle D Transplantation. 2024; 108(6):1308-1318.

PMID: 38361243 PMC: 11136607. DOI: 10.1097/TP.0000000000004934.


Translating B cell immunology to the treatment of antibody-mediated allograft rejection.

Heeger P, Haro M, Jordan S Nat Rev Nephrol. 2024; 20(4):218-232.

PMID: 38168662 DOI: 10.1038/s41581-023-00791-0.